Novozymes says biofuels to drive growth, shares hit record

Danish industrial enzyme maker Novozymes said earnings growth would accelerate this year and next, driven by demand for biofuels, sending its shares to a record high.

The world's largest producer of enzymes used in detergents, bioethanol, food and beer reported fourth-quarter profit in line with analyst forecasts. It said most of its growth in 2014 would be from bioenergy, even though U.S. ethanol production was flat last year.

(Watch: Ethanol biofuel is the 'next big thing': Novozymes CEO)

"We still have lots of technology to implement, so it's still an area which will contribute with high growth," Novozymes Chief Financial Officer Benny Loft told Reuters.

Novozymes, which competes in the biofuel enzymes market with U.S. chemicals group DuPont, posted a 9 percent increase in sales to the Bioenergy industry in 2013.

It expects operating profit growth of 6 to 9 percent this year, up from 6 percent in 2013, and maintained guidance for 10 percent growth in earnings before interest and tax (EBIT) from 2015.

"The 2014 guidance looks strong,especially when we know the management used to give conservative outlooks," analyst Michael Friis Jorgensen from Alm. Brand Markets said.

(Read more: Novozymes CEO: Our board holds few shares in the company)

In December last year, Novozymes and U.S.-based Monsanto Co. formed an alliance for the research and commercialisation of microbial products for agriculture. The deal will have a negative impact on sales growth of up to 1 percentage point this year.

EBIT rose to 703 million Danish crowns ($128 million) in the October to December quarter from a year-earlier 671 million crowns and against an average forecast of 699 million crowns in a Reuters poll of analysts.

Shares in Novozymes were up 2.6 percent at 0803 GMT at 244.60 crowns, a record high. It trades on a forward 12-month price-to-earnings ratio of 30.9, around twice a sector median of 16.5 for peers in Europe, Reuters data showed.

Follow us on Twitter: @CNBCWorld

Contact Europe News


    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Europe Video

  • FX markets: Reading the Fed

    If there's more dovish comment from the Federal Reserve tomorrow, will there be a big reaction in euro-dollar? Michael Sneyd, FX analyst at BNP Paribas, weighs in.

  • Is Apple's iPhone growth a 'home run'?

    Daniel Ives, managing director at FBR Capital Markets, discusses the growth in iPhone sales, saying Apple scored a "home run", with bigger screens "selling like hot cakes" in places like China.

  • UK growth data was 'disappointing'

    Ross Walker, senior U.K. economist at RBS, says that the British economy looks "meaningfully weaker" than the Bank of England's indicates.